Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemiaQi Qu, Depei Wu, Limin Liu et al.|Leukemia Research|2015Cited by 12
Efficacy of cytarabine, aclarubicin and granulocyte colony-stimulating factor (CAG) regimen compared to FLAG regimen for adult patients with relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaXiaoli Li, Depei Wu, Limin Liu et al.|Leukemia Research|2015Cited by 7